FDA Inspection 1321714 — Medartis Inc.

Medartis Inc. — FEI 3009540749

The FDA completed an inspection of Medartis Inc. on Jun 3, 2026 in Warsaw, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 3, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Warsaw, IN (United States)

Citations

IDCFRDescription
23209ISO 13485:2016 Clause 8.1Methods for monitoring, measurement, analysis, and improvement not determined
23213ISO 13485:2016 Clause 8.2.1Information gathered in feedback process not used as input into risk management
23249ISO 13485:2016 Clause 8.4Procedures for analysis of data not documented

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.